Molecular Partners
Develops designed ankyrin repeat protein platform therapies used in ophthalmology, oncology, inflammation, and other therapeutic treatments.
Market cap
$136m
Enterprise value
($24m)
Share price
$3.82 MOLN
Company register number
CH-020.3.028.228-2
Authorizing premium user...